Table 1.
Demographics and clinical characteristics of the study population.
| Cirrhotic with CDI Patients Mean (±S.D.)/Number of Patients (%) Total n = 25 |
|
|---|---|
| Age (years) | 65.8 (±8.06) |
| Alcohol | 20 (80%) |
| Death (yes) | 11 (44%) |
| Time between admission and CDI diagnosis | 4.16 (±1.4) |
| Viral | |
| HBV | 3 (12%) |
| HCV | 5 (20%) |
| No | 17 (68%) |
| Hepatic cancer | 7 (28%) |
| ICU | 15 (60%) |
| Atlas score | 4.32 (2.3) |
| PPI | 23 (92%) |
| Rifaximin | 5 (20%) |
| Encephalopathy | 20 (80%) |
| Ascites | 25 (100%) |
| SBP | 5 (20%) |
| CRP (mg/mL) | 50.4 (±23.82) |
| Leukocytes (cells/μL) | 15,610.68 (±6900.72) |
| Neutrophils (%) | 79.61 (±9.78) |
| Erythrocytes (cells/μL) | 5305.44 (±6422.44) |
| Haematocrit (%) | 27.61 (±7.67) |
| Glomerular filtration rate (mL/min/1.73 m2) | 73.42 (±45.55) |
| Na (mEq/L) | 129.96 (±4.84) |
| K (mEq/L) | 4.45 (±0.85) |
PPI, proton pump inhibitor; ICU, intensive care unit; SBP, spontaneous bacterial peritonitis; CRP, C-reactive protein.